Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead drug candidate, AD04, is being developed for the treatment of Alcohol Use Disorder in patients with a specific 5-HT3 genomic biomarker.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.